Live Breaking News & Updates on Pharma bashir

Stay informed with the latest breaking news from Pharma bashir on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pharma bashir and stay connected to the pulse of your community

Pengadaan Vaksin COVID-19, HSBC Kasih Pembiayaan Bio Farma Rp2,6 T

Pembiayaan dengan skema dana talangan dai HSBC itu, telah dikucurkan dalam tiga tahap untuk pengadaan vaksin COVID-19 oleh Bio Farma.

Indonesia , Pharma-bashir , Procurement-vaccine , Financing-pharma , Atomic-number , President-director-atomic-number , Government-indonesia , Director-main-pharma-bashir , Hsbc , Aksin , Aksinasi

Penjualan Holding BUMN Farmasi Tembus Rp15 Triliun pada Semester 1 2021

Pandemi Covid-19 menjadi tantangan terbesar Bio Farma sebagai induk Holding BUMN Farmasi, yang baru dibentuk pada 31 Januari 2020, atau tepat dua bulan sebelum pandemi.

Indonesia , Bandung , Jawa-barat , Pharma-bashir , Sales-pharmacy-translucent-trillion , Bandung-atomic-number , Parent-pharmacy , Chemistry-pharma , Director-main-pharma-bashir , Performance-pharmacy-semesters-with , Vaccination-cooperation-together

HSBC Kucurkan Pembiayaan Rp2,64 Triliun ke Bio Farma untuk Impor Vaksin

Ketersediaan dan akses terhadap vaksin masih menjadi tantangan bagi Indonesia, dan negara lain di dunia. Untuk itu, HSBC turut berkontribusi dalam upaya pembiayaan tersebut.

Indonesia , Jakarta , Jakarta-raya , Pharma-bashir , Feedstock-drugs , Import-vaccine , Atomic-number , President-director , Read-also , Wanted-press-import-feedstock-drugs , Director-main-pharma-bashir , Type-vaccine

HSBC Indonesia beri Bio Farma 185 juta dolar untuk impor vaksin

PT Bank HSBC Indonesia telah memberikan pembiayaan hingga 185 juta dolar AS kepada Bio Farma guna mendukung badan usaha milik negara dalam bidang farmasi itu ...

Indonesia , Jakarta , Jakarta-raya , Pharma-bashir , Atomic-number , Government-indonesia , President-director-atomic-number , Director-main-pharma-bashir , Director-finance , Management-risk , Director-banking-commercial

Bio Farma targetkan penguasaan teknologi baru produksi vaksin Covid-19

Bio Farma targetkan penguasaan teknologi baru produksi vaksin Covid-19
antaranews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from antaranews.com Daily Mail and Mail on Sunday newspapers.

United-states , Indonesia , Jakarta , Jakarta-raya , Pharma-bashir , Recovery-national-thohir , Executor-committee , Indonesia-jakarta , Atomic-number , Director-main-pharma-bashir , According-to-her , Vaccine-red-white

DPR dorong BUMN Farmasi bersinergi terkait diplomasi penyediaan vaksin

DPR dorong BUMN Farmasi bersinergi terkait diplomasi penyediaan vaksin
antaranews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from antaranews.com Daily Mail and Mail on Sunday newspapers.

Indonesia , South-korea , Jakarta , Jakarta-raya , Situmorang , Sumatera-utara , Pharma-bashir , Pfizer , Members-commission-maryam-hadrat , Commission-anton-sukartono-suratto , Committee-diplomacy-foreign , Prevention-commission-view-do

DPR Minta BUMN Farmasi Lebih Bersinergi untuk Diplomasi Penyediaan Vaksin

DPR Minta BUMN Farmasi Lebih Bersinergi untuk Diplomasi Penyediaan Vaksin
merdeka.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from merdeka.com Daily Mail and Mail on Sunday newspapers.

Indonesia , South-korea , Pharma-bashir , Pfizer , Members-commission-maryam-hadrat , Commission-anton-sukartono-suratto , Committee-diplomacy-foreign , Prevention-commission-view-do , Ask-pharmacy-more-synergy , Diplomacy-provision-vaccine , Pharmacy-as-pharma , Prevention-commission-view